Filing Details
- Accession Number:
- 0001179110-18-014209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-21 07:22:42
- Reporting Period:
- 2018-12-20
- Accepted Time:
- 2018-12-21 07:22:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1557341 | T Christopher Cox | 8 Sylvan Way Parsippany NJ 07054 | Evp & Chief Corp. Dev. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-20 | 113,500 | $17.70 | 334,955 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 60,308 | Direct |
Footnotes
- Represents the weighted average purchase price of the shares purchased ranging from a low of $17.56 to a high of $17.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- The shares are held by a trust of which the reporting person is the trustee. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein